All News


Guilt by association, an opinion

Scientists who follow government advice and take up links with industry could find that not everyone will see them in a positive light.

Roche buys Zürich spin-off

Acquisition gives Roche access to antibody-boosting technology - and possible anti-cancer treatments in the pipeline

From lab to boardroom

How a Swiss university spin-off got to exit in six years - Interview with Joël Jean-Mairet, Chief Executive Officer and Joint Founder, GlycArt.

A serial entrepeneur

By mixing academic research with commercial ventures, Sir Richard Friend has returned to the scientific traditions of Faraday and Kelvin. He has also created a new role model for the modern scientist.

Patently Ridiculous

Barry Fox thinks that the patent system is deliberately designed to make it hard to find out anything.